SPECIFIC PHARMA A/S: Financial statements 2024
CVR: 33161395
SPECIFIC PHARMA A/S (CVR 33161395) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 210,987,000 and a net result of DKK 25,560,000 compared with DKK 9,876,000 the year before. That is an increase of 18.8% compared with the year before. The profit margin was 12.1%. Equity amounted to DKK 106,245,000. The solvency ratio was 84.2%. The company had 25 employees in the financial year.
- Revenue
- 210,987,000 kr.
- Gross Profit
- 48,547,000 kr.
- Profit/Loss
- 25,560,000 kr.
- Equity
- 106,245,000 kr.
- Total Assets
- 126,169,000 kr.
- Employees
- 25
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 211 mio. | 48.5 mio. | 25.6 mio. | 106.2 mio. | 25 |
| 2023 | 177.6 mio. | 34.7 mio. | 9.9 mio. | 89.6 mio. | 25 |
| 2022 | 123.3 mio. | 26.4 mio. | 7.8 mio. | 85.5 mio. | 23 |
| 2021 | 139.6 mio. | 32.5 mio. | 14.8 mio. | 88.8 mio. | 21 |
| 2020 | 128.2 mio. | 27 mio. | 8.2 mio. | 80.2 mio. | 16 |
How creditworthy is SPECIFIC PHARMA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout SPECIFIC PHARMA A/S
SPECIFIC PHARMA A/S is a Danish company of the type Aktieselskab based in København SV, founded in 2010. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Uffe Kåre Jensen. The company is owned by NOMECO A/S. The company has 24 employees. In 2026, the company reported revenue of DKK 157,797,000 and a net result of DKK 15,192,000 compared with DKK 29,239,000 the year before. Equity amounted to DKK 98,645,000.
